REJUVENATE BIO INC — Department of Defense SBIR Phase II: SOCOM172-002

REJUVENATE BIO INC — SBIR Phase II award from Department of Defense.

Amount
$1,441,267
Agency
Department of Defense · Special Operations Command
Program / Phase
SBIR · Phase II
Topic
SOCOM172-002
Solicitation
2017.2
NAICS
Place of performance
MA
Period
2018-11-29 → 2020-11-27

Description

Multi-Purpose Canines (MPCs) are an integral aspect of the US military. The continued expansion and use of these indispensable force multipliers in an intense, ever-changing and complex battlefield requires enhancing their innate capabilities in a timely manner. Additionally, canines have a relatively short life span, and considering the substantial training period that MPCs must undergo, their effective working time is even more limited. Completion of this Phase II study will provide evidence of the translatability of these therapies and prove their ability to enhance canine performance. By overcoming the inherent delays and scaling issues of traditional breeding programs, gene therapies will enable the rapid distribution of performance enhancements to current and future MPCs.